David W. Morris

5.5k total citations
74 papers, 3.5k citations indexed

About

David W. Morris is a scholar working on Pharmacology, Experimental and Cognitive Psychology and Psychiatry and Mental health. According to data from OpenAlex, David W. Morris has authored 74 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pharmacology, 22 papers in Experimental and Cognitive Psychology and 20 papers in Psychiatry and Mental health. Recurrent topics in David W. Morris's work include Treatment of Major Depression (29 papers), Mental Health Research Topics (18 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (15 papers). David W. Morris is often cited by papers focused on Treatment of Major Depression (29 papers), Mental Health Research Topics (18 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (15 papers). David W. Morris collaborates with scholars based in United States, Singapore and China. David W. Morris's co-authors include Madhukar H. Trivedi, A. John Rush, Stephen R. Wisniewski, Julia K. Warnock, Andrew A. Nierenberg, Diane Warden, Gunvant K. Thaker, Maurizio Fava, Benji T. Kurian and Mustafa M. Husain and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

David W. Morris

73 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David W. Morris United States 36 1.0k 994 763 663 527 74 3.5k
Mary E. Kelley United States 42 1.3k 1.2× 766 0.8× 719 0.9× 726 1.1× 955 1.8× 126 5.3k
Susan Ball United States 40 798 0.8× 708 0.7× 965 1.3× 856 1.3× 397 0.8× 142 5.9k
Steven D. Targum United States 36 2.1k 2.0× 1.0k 1.1× 962 1.3× 1.1k 1.7× 718 1.4× 134 5.5k
Takefumi Suzuki Japan 37 2.6k 2.5× 797 0.8× 430 0.6× 766 1.2× 374 0.7× 234 4.6k
E. Sherwood Brown United States 42 1.6k 1.5× 463 0.5× 355 0.5× 757 1.1× 364 0.7× 165 5.7k
Patricia K. Corey‐Lisle United States 22 1.3k 1.2× 818 0.8× 370 0.5× 545 0.8× 560 1.1× 44 3.1k
Ru‐Band Lu Taiwan 37 1.1k 1.0× 527 0.5× 387 0.5× 594 0.9× 472 0.9× 146 5.2k
Jeffrey A. Welge United States 42 2.5k 2.3× 972 1.0× 515 0.7× 1.5k 2.3× 788 1.5× 163 5.8k
Yong Min Ahn South Korea 31 1.4k 1.4× 289 0.3× 554 0.7× 729 1.1× 368 0.7× 202 3.7k
Jess G. Fiedorowicz United States 36 2.0k 1.9× 464 0.5× 406 0.5× 914 1.4× 288 0.5× 179 4.1k

Countries citing papers authored by David W. Morris

Since Specialization
Citations

This map shows the geographic impact of David W. Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David W. Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David W. Morris more than expected).

Fields of papers citing papers by David W. Morris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David W. Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David W. Morris. The network helps show where David W. Morris may publish in the future.

Co-authorship network of co-authors of David W. Morris

This figure shows the co-authorship network connecting the top 25 collaborators of David W. Morris. A scholar is included among the top collaborators of David W. Morris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David W. Morris. David W. Morris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Croarkin, Paul E., Paul A. Nakonezny, David W. Morris, et al.. (2024). Performance and Psychometric Properties of Novel Brief Assessments for Depression in Children and Adolescents. PubMed. 3(2). 335–343. 1 indexed citations
2.
Haley, Charlotte, Betsy D. Kennard, David W. Morris, et al.. (2023). The Quick Inventory of Depressive Symptomatology, Adolescent Version (QIDS-A17): A Psychometric Evaluation. Neuropsychiatric Disease and Treatment. Volume 19. 1085–1102. 4 indexed citations
3.
Morris, David W.. (2019). <p>Adaptive Affect: The Nature of Anxiety and Depression</p>. Neuropsychiatric Disease and Treatment. Volume 15. 3323–3326. 5 indexed citations
4.
Nakonezny, Paul A., David W. Morris, Tracy L. Greer, et al.. (2015). Evaluation of anhedonia with the Snaith–Hamilton Pleasure Scale (SHAPS) in adult outpatients with major depressive disorder. Journal of Psychiatric Research. 65. 124–130. 40 indexed citations
5.
6.
Sung, Sharon C., Charlotte Haley, Stephen R. Wisniewski, et al.. (2012). The Impact of Chronic Depression on Acute and Long-Term Outcomes in a Randomized Trial Comparing Selective Serotonin Reuptake Inhibitor Monotherapy Versus Each of 2 Different Antidepressant Medication Combinations. The Journal of Clinical Psychiatry. 73(7). 967–976. 24 indexed citations
7.
Ivleva, Elena I., David W. Morris, Amanda F. Moates, et al.. (2012). Cognitive endophenotypes of psychosis within dimension and diagnosis. Psychiatry Research. 196(1). 38–44. 44 indexed citations
8.
Rush, A. John, Madhukar H. Trivedi, Jonathan W. Stewart, et al.. (2011). Combining Medications to Enhance Depression Outcomes (CO-MED): Acute and Long-Term Outcomes of a Single-Blind Randomized Study. American Journal of Psychiatry. 168(7). 689–701. 275 indexed citations
9.
Trivedi, Madhukar H., Stephen R. Wisniewski, David W. Morris, et al.. (2011). Concise Health Risk Tracking Scale. The Journal of Clinical Psychiatry. 72(6). 757–764. 128 indexed citations
10.
Rush, A. John, Andrew A. Nierenberg, Madhukar H. Trivedi, et al.. (2011). Correlates and outcomes of depressed out-patients with greater and fewer anxious symptoms: a CO-MED report. The International Journal of Neuropsychopharmacology. 15(10). 1387–1399. 25 indexed citations
11.
Zisook, Sidney, Ira M. Lesser, Barry D. Lebowitz, et al.. (2011). Effect of Antidepressant Medication Treatment on Suicidal Ideation and Behavior in a Randomized Trial. The Journal of Clinical Psychiatry. 72(10). 1322–1332. 47 indexed citations
12.
Daly, Ella, Madhukar H. Trivedi, Maurizio Fava, et al.. (2010). The Relationship Between Adverse Events During Selective Serotonin Reuptake Inhibitor Treatment for Major Depressive Disorder and Nonremission in the Suicide Assessment Methodology Study. Journal of Clinical Psychopharmacology. 31(1). 31–38. 16 indexed citations
13.
Nakonezny, Paul A., Thomas Carmody, David W. Morris, Benji T. Kurian, & Madhukar H. Trivedi. (2010). Psychometric evaluation of the Snaith–Hamilton pleasure scale in adult outpatients with major depressive disorder. International Clinical Psychopharmacology. 25(6). 328–333. 100 indexed citations
14.
Morris, David W., Madhukar H. Trivedi, Maurizio Fava, et al.. (2009). Diurnal mood variation in outpatients with major depressive disorder. Depression and Anxiety. 26(9). 851–863. 24 indexed citations
15.
Leuchter, Andrew F., Ira M. Lesser, Madhukar H. Trivedi, et al.. (2008). An Open Pilot Study of the Combination of Escitalopram and Bupropion-SR for Outpatients with Major Depressive Disorder. Journal of Psychiatric Practice. 14(5). 271–280. 34 indexed citations
16.
Morris, David W., A. John Rush, Shailesh Jain, et al.. (2007). Diurnal Mood Variation in Outpatients With Major Depressive Disorder. The Journal of Clinical Psychiatry. 68(9). 1339–1347. 33 indexed citations
17.
Trivedi, Madhukar H., David W. Morris, Jiyang Pan, Bruce D. Grannemann, & A. John Rush. (2005). What moderator characteristics are associated with better prognosis for depression?. Neuropsychiatric Disease and Treatment. 1(1). 51–57. 38 indexed citations
18.
Warnock, Julia K. & David W. Morris. (2003). Adverse Cutaneous Reactions to Mood Stabilizers. American Journal of Clinical Dermatology. 4(1). 21–30. 38 indexed citations
19.
Warnock, Julia K., et al.. (1999). Female hypoactive sexual disorder: Case studies of physiologic androgen replacement. Journal of Sex & Marital Therapy. 25(3). 175–182. 7 indexed citations
20.
Lin, Baochuan, David W. Morris, & Janice Y. Chou. (1998). Hepatocyte Nuclear Factor 1α Is an Accessory Factor Required for Activation of Glucose-6-Phosphatase Gene Transcription by Glucocorticoids. DNA and Cell Biology. 17(11). 967–974. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mary E. Kelley Breakdown of academic impact, for papers by Susan Ball Breakdown of academic impact, for papers by Steven D. Targum Breakdown of academic impact, for papers by Takefumi Suzuki Breakdown of academic impact, for papers by E. Sherwood Brown Breakdown of academic impact, for papers by Patricia K. Corey‐Lisle Breakdown of academic impact, for papers by Ru‐Band Lu Breakdown of academic impact, for papers by Jeffrey A. Welge Breakdown of academic impact, for papers by Yong Min Ahn Breakdown of academic impact, for papers by Jess G. Fiedorowicz
Rankless by CCL
2026